JNJ

170.73

-0.23%↓

ABBV

198.59

+0.8%↑

AZN

74.43

-0.13%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

JNJ

170.73

-0.23%↓

ABBV

198.59

+0.8%↑

AZN

74.43

-0.13%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

JNJ

170.73

-0.23%↓

ABBV

198.59

+0.8%↑

AZN

74.43

-0.13%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

JNJ

170.73

-0.23%↓

ABBV

198.59

+0.8%↑

AZN

74.43

-0.13%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

JNJ

170.73

-0.23%↓

ABBV

198.59

+0.8%↑

AZN

74.43

-0.13%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

Search

TuHURA Biosciences Inc

Geschlossen

2.64 2.33

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

2.53

Max

2.64

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+363.32% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

14. Aug. 2025

TuHURA Biosciences Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

5. Aug. 2025, 23:11 UTC

Ergebnisse

Australia's REA Hikes Dividend as Annual Profit Rises 23% -- Update

5. Aug. 2025, 22:45 UTC

Ergebnisse

Australia's REA Hikes Dividend as Annual Profit Rises 23%

5. Aug. 2025, 22:39 UTC

Ergebnisse

Great-West Lifeco Logs Lower 2Q Profit

5. Aug. 2025, 21:32 UTC

Ergebnisse

Coupang Posts Higher 2Q Sales Due to Customer Growth

6. Aug. 2025, 00:00 UTC

Akquisitionen, Fusionen, Übernahmen

NFL to Take 10% Stake in Disney's ESPN -- WSJ

6. Aug. 2025, 00:00 UTC

Akquisitionen, Fusionen, Übernahmen

The NFL Is Taking a 10% Stake in Disney's ESPN -- WSJ

6. Aug. 2025, 00:00 UTC

Akquisitionen, Fusionen, Übernahmen

Disney to Take Control of NFL Network as Part of Agreement -- WSJ

6. Aug. 2025, 00:00 UTC

Akquisitionen, Fusionen, Übernahmen

Disney, NFL Strike Wide-Reaching Media-Asset Deal -- WSJ

5. Aug. 2025, 23:48 UTC

Market Talk

Nikkei May Decline Amid U.S. Economic Uncertainty -- Market Talk

5. Aug. 2025, 23:40 UTC

Market Talk

Gold Edges Higher, Supported by Fed Rate-Cut Hopes -- Market Talk

5. Aug. 2025, 23:19 UTC

Market Talk

Lindian Deal With Iluka Demonstrates Kangankunde Project Appeal -- Market Talk

5. Aug. 2025, 23:03 UTC

Market Talk
Ergebnisse

Advanced Micro Devices' Data-Center Story Seen as Promising -- Market Talk

5. Aug. 2025, 22:22 UTC

Ergebnisse

REA: Expectation of More Interest-Rate Cuts Likely to Support Buyer Demand>REA.AU

5. Aug. 2025, 22:21 UTC

Ergebnisse

REA Expects FY26 Listing Volumes Broadly Flat on FY25>REA.AU

5. Aug. 2025, 22:20 UTC

Ergebnisse

REA Expects September-Quarter Listings to Be Down on Year>REA.AU

5. Aug. 2025, 22:18 UTC

Ergebnisse

REA July 2025 New Residential Listings Down 8% on Year>REA.AU

5. Aug. 2025, 22:17 UTC

Ergebnisse

REA FY25 Australian Residential Listings Up 1% on Year>REA.AU

5. Aug. 2025, 22:17 UTC

Ergebnisse

REA FY25 India Revenue A$129M Vs. A$103M>REA.AU

5. Aug. 2025, 22:16 UTC

Ergebnisse

REA FY25 Core Australia Revenue A$1.54B Vs. A$1.35B>REA.AU

5. Aug. 2025, 22:16 UTC

Ergebnisse

REA FY25 Core Operations Net Profit A$564.4M Vs. A$460.5M>REA.AU

5. Aug. 2025, 22:15 UTC

Ergebnisse

REA Group FY25 Ebitda A$969.2M Vs. A$824.8M>REA.AU

5. Aug. 2025, 22:13 UTC

Ergebnisse

REA Group Raises Dividend to A$1.38 Vs. A$1.02 >REA.AU

5. Aug. 2025, 22:13 UTC

Ergebnisse

REA Group FY25 Rev A$1.67B Vs. A$1.45B >REA.AU

5. Aug. 2025, 22:12 UTC

Ergebnisse

REA FY25 Core Operations Net Profit A$564.4M Vs, A$460.5M>REA.AU

5. Aug. 2025, 22:12 UTC

Ergebnisse

REA Group FY25 Net A$677.9M Vs. Net A$302.8M >REA.AU

5. Aug. 2025, 21:58 UTC

Ergebnisse

Novo Nordisk's Earnings Come After a Dramatic Guidance Cut. What to Look for Now. -- Barrons.com

5. Aug. 2025, 21:30 UTC

Ergebnisse

AMD Gives a Strong Outlook. Why the Stock Is Falling. -- Barrons.com

5. Aug. 2025, 21:26 UTC

Ergebnisse

AMD CEO Expects Embedded Segment to Return to Sequential Growth in Back Half of 2025

5. Aug. 2025, 21:23 UTC

Ergebnisse

AMD CEO Sees Strong Customer Interest in MI400 Series for Large-Scale Deployments

5. Aug. 2025, 21:17 UTC

Ergebnisse

AMD Expects Steep Production Ramp for MI350 Series in Back Half of Year, CEO Says

Peer-Vergleich

Kursveränderung

TuHURA Biosciences Inc Prognose

Kursziel

By TipRanks

363.32% Vorteil

12-Monats-Prognose

Durchschnitt 12 USD  363.32%

Hoch 15 USD

Tief 9 USD

Basierend auf 3 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für TuHURA Biosciences Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

3 ratings

3

Buy

0

Halten

0

Sell

Finanzen

$